The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation.


< Compositions and methods for non-targeted activation of endogenous genes

> Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer

> Modulators of the glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof

~ 00538